Rise Advisors, LLC Apellis Pharmaceuticals, Inc. Transaction History
Rise Advisors, LLC
- $249 Million
- Q3 2025
A detailed history of Rise Advisors, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 18 shares of APLS stock, worth $452. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18Holding current value
$452% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
296Shares Held
132MCall Options Held
2.97MPut Options Held
623K-
Avoro Capital Advisors LLC New York, NY12.2MShares$307 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$299 Million17.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$255 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.75MShares$245 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.98MShares$226 Million0.03% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.76B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...